Literature DB >> 12208645

High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial.

Stuart Brody1.   

Abstract

BACKGROUND: Ascorbic acid (AA) modulates catecholaminergic activity, decreases stress reactivity, approach anxiety and prolactin release, improves vascular function, and increases oxytocin release. These processes are relevant to sexual behavior and mood.
METHODS: In this randomized double-blind, placebo-controlled 14 day trial of sustained-release AA (42 healthy young adults; 3000 mg/day Cetebe) and placebo (39 healthy young adults), subjects with partners recorded penile-vaginal intercourse (FSI), noncoital partner sex, and masturbation in daily diaries, and also completed the Beck Depression Inventory before and after the trial.
RESULTS: The AA group reported greater FSI (but, as hypothesized, not other sexual behavior) frequency, an effect most prominent in subjects not cohabiting with their sexual partner, and in women. The AA but not placebo group also experienced a decrease in Beck Depression scores.
CONCLUSIONS: AA appears to increase FSI, and the differential benefit to noncohabitants suggests that a central activation or disinhibition, rather than peripheral mechanism may be responsible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208645     DOI: 10.1016/s0006-3223(02)01329-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  24 in total

1.  Lifestyle drugs, mood, behaviour and cognition.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

Review 2.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

Review 3.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

Review 4.  Nutrition and depression: implications for improving mental health among childbearing-aged women.

Authors:  Lisa M Bodnar; Katherine L Wisner
Journal:  Biol Psychiatry       Date:  2005-07-25       Impact factor: 13.382

5.  Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice.

Authors:  Morgana Moretti; Josiane Budni; Danubia Bonfanti Dos Santos; Alessandra Antunes; Juliana Felipe Daufenbach; Luana Meller Manosso; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  J Mol Neurosci       Date:  2012-10-03       Impact factor: 3.444

6.  Evidence for the involvement of opioid system in the antidepressant-like effect of ascorbic acid.

Authors:  Morgana Moretti; Camille M Ribeiro; Vivian B Neis; Luis Eduardo B Bettio; Priscila B Rosa; Ana Lúcia S Rodrigues
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-08       Impact factor: 3.000

7.  An exploratory factor analysis of nutritional biomarkers associated with major depression in pregnancy.

Authors:  Lisa M Bodnar; Katherine L Wisner; James F Luther; Robert W Powers; Rhobert W Evans; Marcia J Gallaher; P K Newby
Journal:  Public Health Nutr       Date:  2011-12-08       Impact factor: 4.022

Review 8.  Preventive and Therapeutic Potential of Vitamin C in Mental Disorders.

Authors:  Qian-Qian Han; Tian-Tian Shen; Fang Wang; Peng-Fei Wu; Jian-Guo Chen
Journal:  Curr Med Sci       Date:  2018-03-15

9.  Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid.

Authors:  M Elizabeth Meredith; James M May
Journal:  Brain Res       Date:  2013-10-01       Impact factor: 3.252

10.  Effects of fasting therapy on irritable bowel syndrome.

Authors:  Motoyori Kanazawa; Shin Fukudo
Journal:  Int J Behav Med       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.